Latest Independent Expert Reports News

Qoria Limited updates shareholders on its proposed merger with Aura Consolidated Group, highlighting Aura's robust financial performance and cost-saving initiatives. The merger remains unanimously recommended by Qoria's board, pending regulatory and shareholder approvals.

Insignia Financial has secured a crucial regulatory approval from APRA, advancing the proposed acquisition by Daintree BidCo. The deal now moves closer to a shareholder vote scheduled for mid-April.

The Supreme Court of New South Wales has approved the convening of meetings for National Storage REIT securityholders to vote on a $2.86 per security acquisition offer by a Brookfield-GIC consortium. The independent expert report supports the transaction as fair and reasonable, with the NSR Board unanimously recommending approval.

African Gold Ltd has proposed a scheme of arrangement for Montage Gold Corp to acquire 100% of its shares, with an independent expert endorsing the deal as fair and reasonable. The African Gold board unanimously recommends shareholder approval, setting the stage for a significant consolidation in Côte d'Ivoire’s gold sector.

Earth’s Energy has settled a dispute with minority shareholders over its South Australian geothermal joint venture, agreeing to payments and transferring its JV interest subject to shareholder approval.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

Apiam Animal Health shareholders convened on 3 February 2026 to vote on a scheme of arrangement proposing acquisition by Adamantem Capital Fund II, with the board unanimously recommending approval. The scheme offers $0.87 cash per share or scrip alternatives, pending final court approval.

ChemX Materials Limited remains suspended from ASX trading as it finalises overdue financial reports and secures informal funding, aiming for share reinstatement.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

Elanor Investors Group has extended the deadline for dispatching its Notice of Meeting related to the Rockworth Capital Partners transaction, with the Extraordinary General Meeting now expected in early February 2026.

Global Uranium and Enrichment Limited (GUE) has registered its scheme booklet with ASIC, detailing the proposed acquisition by Snow Lake Resources Ltd. The independent expert report supports the fairness and reasonableness of the deal, with GUE directors unanimously recommending shareholder approval.

WRKR Limited has agreed to acquire PaidRight, a leading payroll compliance platform, in a strategic move to expand beyond superannuation compliance. The deal, valued at approximately A$11.4 million, aims to integrate advanced real-time payroll compliance technology into WRKR’s platform.